EU CHMP recommends TRYNGOLZA approval for severe hypertriglyceridemia
The European Medicines Agency’s Committee for Medicinal Products for Human Use recommended TRYNGOLZA (olezarsen) for approval in the EU for severe hypertriglyceridemia.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.